Recall Register

Device recall: EMBLEM S-ICD Subcutaneous Electrode Model 3501. Component of implantable cardioverter defibrillator (ICD)

Class I FDA enforcement event 87014. Recall start date: . Status in the FDA record: Terminated. Termination date: .

Reason for recall, in the words of FDA

There is potential for fractures which results in the inability to delivery therapy.

Class I, in the words of FDA

a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death

Boston Scientific Corporation started this device recall on 13 Nov 2020. The firm address in the FDA record is in Saint Paul, MN. FDA put the recall in Class I. FDA event 87014 has 1 product record. The first FDA enforcement report date is 27 Jan 2021. The record gives the status Terminated, with the termination date 23 Jul 2024.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

Worldwide distribution including US and US territories, Canada, Latin America, Europe, Middle East, Africa, and Asia-Pacific region

Recalling firm

Boston Scientific Corporation, Saint Paul, MN.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

1 product record in the event.

FDA event 87014: product records
Recall numberProductQuantityClassStatusReport date
Z-0879-2021EMBLEM S-ICD Subcutaneous Electrode Model 3501. Component of implantable cardioverter defibrillator (ICD)47000 unitsClass ITerminated27 Jan 2021

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class I: The highest of the three FDA recall classes.

The event in context

Device events that started in 2020
916
Share of these events in Class I
4%
Product records in this event
1Median of the firm: 2
Events of the firm on the register
162

Other events of the firm

Official channels

Cite this page

Recall Register. FDA enforcement event 87014. https://recallregister.com/fda/i/87014/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA device enforcement reports
Licence
CC0 1.0
Export date
28 Sep 2026
Newest FDA report date on the register
23 Sep 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: Worldwide distribution including US and US territories, Canada, Latin America, Europe, Middle East, Africa, and Asia-Pacific region
What quantity of product is in FDA event 87014?
The FDA record gives this quantity: 47000 units
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many device recalls of 2020 have the same class?
4% of the 916 device events that started in 2020 are in Class I.